Stipple Bio
Stipple Bio is a startup headquartered in Cambridge, United States, founded in 2021. It has raised at least $74.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Stipple Bio has raised at least $74.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Stipple Bio sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Cambridge
- 2Pi
- Acceleron Fusion
- actnano
- AIScientists
- Apeiron Labs
- Aptamino
- Arches Medical Independents
- Aviceda Therapeutics
- Axoft
- Blitzy
- Caldera Therapeutics
Related
- Innovation profile of Cambridge
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Stipple Bio do?
Stipple Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Stipple Bio raised?
At least $74.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Stipple Bio based?
Stipple Bio is headquartered in Cambridge, United States.
When was Stipple Bio founded?
Stipple Bio was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.